Abstract
We discuss the current status of liquid biopsy and its advantages and challenges with a focus on pre-analytical sample handling, technologies and workflows. The potential of circulating tumor cells and circulating tumor DNA is pointed out and an overview of corresponding technologies is given.
Author supplied keywords
Cite
CITATION STYLE
APA
Neumann, M. H. D., Bender, S., Krahn, T., & Schlange, T. (2018, January 1). ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress. Computational and Structural Biotechnology Journal. Elsevier B.V. https://doi.org/10.1016/j.csbj.2018.05.002
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free